Wells Fargo
ENZN

Wells Fargo’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Wells Fargo’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-48
Closed – – 6614
2016
Q1 		$0 Buy
48
+1
+2% – ﹤0.01% 6659
2015
Q4 		$0 Sell
47
-954
-95% -$756 ﹤0.01% 6625
2015
Q3 		$1K Buy
1,001
+1
+0.1% +$1 ﹤0.01% 6139
2015
Q2 		$1K Sell
1,000
-2
-0.2% -$3 ﹤0.01% 6299
2015
Q1 		$1K Buy
1,002
+1
+0.1% +$1 ﹤0.01% 6114
2014
Q4 		$1K Buy
1,001
+1
+0.1% +$1 ﹤0.01% 6147
2014
Q3 		$1K Sell
1,000
-1,891
-65% -$2.33K ﹤0.01% 6130
2014
Q2 		$3K Buy
2,891
+1,757
+155% +$1.67K ﹤0.01% 5923
2014
Q1 		$1K Buy
1,134
+133
+13% +$137 ﹤0.01% 5813
2013
Q4 		$1K Buy
+1,001
New +$1.54K ﹤0.01% 5667

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Wells Fargo's ENZN Position: Q2 2016 in Review

Wells Fargo sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 48 shares.

Wells Fargo first reported a position in ENZN in Q4 2013 and held it in 10 quarters. The position peaked at $3K in Q2 2014. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Wells Fargo reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Wells Fargo sold 48 ENZON PHARMACEUTICALS INC shares in Q2 2016.
  • Wells Fargo first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 10 quarters.
  • Wells Fargo's ENZON PHARMACEUTICALS INC position peaked at $3K in Q2 2014.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Wells Fargo's 13F filing for Q2 2016, filed 11 Aug 2016.